Onyx Pharmaceuticals Inc. (ONXX): Today's Featured Health Care Laggard

Onyx Pharmaceuticals ( ONXX) pushed the Health Care sector lower today making it today's featured Health Care laggard. The sector as a whole closed the day up 0.8%. By the end of trading, Onyx Pharmaceuticals fell $1.83 (-1.4%) to $131.17 on average volume. Throughout the day, 2,047,839 shares of Onyx Pharmaceuticals exchanged hands as compared to its average daily volume of 1,538,900 shares. The stock ranged in price between $130.93-$132.90 after having opened the day at $132.50 as compared to the previous trading day's close of $133.00. Other companies within the Health Care sector that declined today were: Mast Therapeutics ( MSTX), down 35.9%, Mazor Robotics ( MZOR), down 8.5%, Tranzyme ( TZYM), down 6.9% and BSD Medical Corporation ( BSDM), down 6.8%.

Onyx Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development and commercialization of therapies that target the molecular mechanisms that cause cancer in the United States and internationally. Onyx Pharmaceuticals has a market cap of $9.7 billion and is part of the drugs industry. Shares are up 76.5% year to date as of the close of trading on Friday. Currently there are 11 analysts that rate Onyx Pharmaceuticals a buy, no analysts rate it a sell, and 2 rate it a hold.

TheStreet Ratings rates Onyx Pharmaceuticals as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. However, as a counter to these strengths, we also find weaknesses including disappointing return on equity and weak operating cash flow.

On the positive front, ImmunoCellular Therapeutics ( IMUC), up 15.1%, Organovo Holdings ( ONVO), up 13.3%, Ambit Biosciences ( AMBI), up 11.6% and Given Imaging ( GIVN), up 10.3% , were all gainers within the health care sector with CareFusion ( CFN) being today's featured health care sector leader.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

null

More from Markets

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Jim Cramer: The 10-Year Yield Could Go to 2.75%

Jim Cramer: The 10-Year Yield Could Go to 2.75%

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%